Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Central nervous system prophylaxis with intrathecal liposomal cytarabine in a subset of high-risk patients with diffuse large B-cell lymphoma receiving first line systemic therapy in a prospective trial.
González-Barca E, Canales M, Salar A, Ferreiro-Martínez JJ, Ferrer-Bordes S, García-Marco JA, Sánchez-Blanco JJ, García-Frade J, Peñalver J, Bello-López JL, Sancho JM, Caballero D; GELTAMO group. González-Barca E, et al. Ann Hematol. 2016 May;95(6):893-9. doi: 10.1007/s00277-016-2648-4. Epub 2016 Mar 30. Ann Hematol. 2016. PMID: 27025508 Free PMC article.
Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling.
Mosquera Orgueira A, Díaz Arias JÁ, Cid López M, Peleteiro Raíndo A, Antelo Rodríguez B, Aliste Santos C, Alonso Vence N, Bendaña López Á, Abuín Blanco A, Bao Pérez L, González Pérez MS, Pérez Encinas MM, Fraga Rodríguez MF, Bello López JL. Mosquera Orgueira A, et al. Among authors: bello lopez jl. BMC Cancer. 2020 Oct 21;20(1):1017. doi: 10.1186/s12885-020-07492-y. BMC Cancer. 2020. PMID: 33087075 Free PMC article.
Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model.
Mosquera Orgueira A, Díaz Arías JÁ, Cid López M, Peleteiro Raíndo A, López García A, Abal García R, González Pérez MS, Antelo Rodríguez B, Aliste Santos C, Pérez Encinas MM, Fraga Rodríguez MF, Bello López JL. Mosquera Orgueira A, et al. Among authors: bello lopez jl. Hemasphere. 2022 Mar 25;6(4):e706. doi: 10.1097/HS9.0000000000000706. eCollection 2022 Apr. Hemasphere. 2022. PMID: 35392483 Free PMC article.
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma.
Mosquera Orgueira A, Díaz Arías JÁ, Serrano Martín R, Portela Piñeiro V, Cid López M, Peleteiro Raíndo A, Bao Pérez L, González Pérez MS, Pérez Encinas MM, Fraga Rodríguez MF, Vallejo Llamas JC, Bello López JL. Mosquera Orgueira A, et al. Among authors: bello lopez jl. Front Oncol. 2023 Apr 28;13:1157646. doi: 10.3389/fonc.2023.1157646. eCollection 2023. Front Oncol. 2023. PMID: 37188190 Free PMC article.
Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data.
Mosquera Orgueira A, González Pérez MS, Díaz Arias JÁ, Antelo Rodríguez B, Alonso Vence N, Bendaña López Á, Abuín Blanco A, Bao Pérez L, Peleteiro Raíndo A, Cid López M, Pérez Encinas MM, Bello López JL, Mateos Manteca MV. Mosquera Orgueira A, et al. Among authors: bello lopez jl. Leukemia. 2021 Oct;35(10):2924-2935. doi: 10.1038/s41375-021-01286-2. Epub 2021 May 18. Leukemia. 2021. PMID: 34007046
The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution.
Mosquera Orgueira A, Antelo Rodríguez B, Alonso Vence N, Díaz Arias JÁ, Díaz Varela N, Pérez Encinas MM, Allegue Toscano C, Goiricelaya Seco EM, Carracedo Álvarez Á, Bello López JL. Mosquera Orgueira A, et al. BMC Cancer. 2019 May 29;19(1):515. doi: 10.1186/s12885-019-5628-y. BMC Cancer. 2019. PMID: 31142279 Free PMC article.
30 results